Evidence map›Paper›PMID 15072469›Full record

ArticleJournal of neuro-oncology

The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Fazilet Kayaselçuk, Suzan Zorludemir, Nebil Bal, Bulent Erdogan, Seyda Erdogan, Tahsin Erman

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Long-term recurrence rates after the removal of spinal meningiomas in relation to Simpson grades.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2016
    Article
  5. Article
  6. Serum survivin increases in prolactinoma.Journal of clinical medicine research · 2015
    Article
  7. Article
  8. SPECT and PET imaging of meningiomas.TheScientificWorldJournal · 2012
    Article
  9. Signals of apoptotic pathways in several types of meningioma.Pathology oncology research : POR · 2011
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fazilet KayaselçukDepartment of Pathology, Faculty of Medicine, Adana Teaching and Medical Research Center, Başkent University, Turkey. faziletks@baskent-adn.edu.tr
Suzan Zorludemir
Nebil Bal
Bulent Erdogan
Seyda Erdogan
Tahsin Erman
Başkent University · TRCukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of proteins involving in the control of proliferation in normal cells may lead to a better understanding of cellular transformation and proliferation mechanisms. Measurement of proliferative activity may help determine the tumor grade, recurrence and malignancy. Forty meningiomas of various histological grade, diagnosed in Baskent University and Cukurova University Medical Faculty, Departments of Pathology, were graded according to WHO grading system and survivin and Ki-67 monoclonal antibodies were administered by immunohistochemical method. Findings were analyzed with statistical methods; distribution of survivin expression and Ki-67 LI values were determined for different grade meningiomas. The correlation between increasing grades of meningiomas, particularly between grades I and III, survivin and Ki-67 LI values was statistically significant. In addition, we have found a positive correlation between clinical outcome, survivin and Ki-67 LI. For over expression of survivin in some of the grade I meningiomas and no or mild expression in some of the grades II and III meningiomas, however, it has been suggested that apoptosis inhibited by survivin is not the only factor responsible for progression of meningiomas.

Indexed as

AdultAgedBiomarkers, TumorFemaleHumansInhibitor of Apoptosis ProteinsKi-67 AntigenMaleMeningeal NeoplasmsMeningiomaMicrotubule-Associated ProteinsMiddle AgedNeoplasm ProteinsSurvivinBiomarkers, TumorBIRC5 protein, humanInhibitor of Apoptosis ProteinsKi-67 AntigenMicrotubule-Associated ProteinsNeoplasm ProteinsSurvivin

Identifiers

PMID15072469
OpenAlexW2035289227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.